The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Amgen to Present at the Baird Growth Stock Conference

Friday, May 04, 2012

Amgen to Present at the Baird Growth Stock Conference16:09 EDT Friday, May 04, 2012THOUSAND OAKS, Calif., May 4, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Baird Growth Stock conference on Wednesday, May 9, 2012, at the Four Seasons Hotel, Chicago, Ill., beginning at 8:20 a.m. Central Daylight Time. Arvind Sood, vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. About AmgenAmgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.CONTACT: Amgen, Thousand OaksChristine Regan, 805-447-5476 (media)Eric Hyllengren, 805-447-1060 (investors)(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)   SOURCE Amgen